Lipid Lowering Therapies And Cholesterol Levels After St-Segment Elevation Myocardial Infarction: Single Center Experience Of Secondary Prevention

Background and Aims: Lipid lowering therapies are the mainstay of secondary prevention after myocardial infarction (MI). However, non-adherence to statins is a major problem that leads to off-target LDL-C levels and higher rates of adverse cardiovascular events.
Source: Atherosclerosis - Category: Cardiology Authors: Tags: Posters 26 - 29 May, 2019 Source Type: research